Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study

Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study

Background The treatment of idiopathic refractory nephrotic syndrome (IRNS) remains a difficult problem in clinical practice. This study aims to determine the efficacy and safety of combining low-dose glucocorticoids with rituximab in IRNS treatment.Methods This prospective, single-center cohort stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Aikeda Yimamuyushan, Youqi Li, Wenwen Jiao, Jianwen Yu, Jianbo Li, Yongjun Shi, Wei Chen, Junbing He, Qinghua Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Idiopathic refractory nephrotic syndrome
rituximab
glucocorticoids
efficacy
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2428330
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items